RETT SYNDROME DNA SEQUENCING (MECP2 MUTATION)

DNA sequencing to detect mutations in the MECP2 gene, which is associated with Rett syndrome, a neurological disorder affecting development.

Also known asRett Syndrome Dna Sequencing (mecp2 Mutation) Rett Syndrome Dna Sequencing (mecp2 Mutation)

Available via

Home Collection, Lab Visit

Contains

3 parameters

Earliest reports in

8 Working Days

Test details

RETT SYNDROME DNA SEQUENCING (MECP2 MUTATION) Test in Bengaluru Overview

Preparations

No special preparations needed

Test included
RETT SYNDROME DNA SEQUENCING (MECP2 MUTATION) includes 3 parameters

  • Specimen Source
  • Preliminary Report
  • Rett Syndrome Dna Sequencing Test (mecp2 Mutation)
Frequently Asked Questions

This test involves sequencing the MECP2 gene to identify mutations associated with Rett Syndrome, a rare neurological disorder primarily affecting females.

It is used to confirm a diagnosis of Rett Syndrome in children with developmental regression, especially after normal early growth.

DNA is extracted from a blood sample and sequenced to look for mutations in the MECP2 gene.

A pathogenic mutation confirms the diagnosis of Rett Syndrome. Absence of mutation may not entirely rule it out, as some variants are undetectable with standard techniques.

No special preparation is needed, but a detailed clinical history is important for accurate interpretation.

Test code

RD1410

Specimen vol. and vacutainer information
SpecimenVacutainerVolume
Edta Whole BloodLavender Vacutainer10

Specimen stability information

Edta Whole Blood

Collection instructions

Clinical History

Specimen rejection criteria

Test run frequency

Every Day TIME - 09:30

Turn around time

8 Working Days

Performing locations

Department

  • Advanced Molecular Diagnostics R&d

CPT and Loinc codes

RETT SYNDROME DNA SEQUENCING (MECP2 MUTATION)

5500